About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Nedd4Gt(XB398)Byg
gene trap XB398, BayGenomics
MGI:3829273
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Nedd4Gt(XB398)Byg/Nedd4Gt(XB398)Byg involves: 129P2/OlaHsd MGI:3829356


Genotype
MGI:3829356
hm1
Allelic
Composition
Nedd4Gt(XB398)Byg/Nedd4Gt(XB398)Byg
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nedd4Gt(XB398)Byg mutation (0 available); any Nedd4 mutation (116 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• following antigen stimulation in fetal liver chimeras, T cell proliferation is less than in similarly treated wild-type chimeras
• however, treatment with IL-2 results in normal proliferation rates

mortality/aging
• no mice are present at weaning

hematopoietic system
• following antigen stimulation in fetal liver chimeras, T cell proliferation is less than in similarly treated wild-type chimeras
• however, treatment with IL-2 results in normal proliferation rates
• in fetal liver chimeras, the percentage of B cell and CD11b+ cells in the lymph nodes and spleens is slightly lower than in wild-type chimeras
• in fetal liver chimeras, the number of T cells in the spleen is larger than in wild-type chimeras
• in fetal liver chimeras, the percentage of CD4+ and CD8+ cells in the lymph nodes and spleens is increased compared to in wild-type chimeras
• in fetal liver chimeras, the percentage of CD4+ and CD8+ cells in the lymph nodes and spleens is increased compared to in wild-type chimeras
• fetal liver chimeras exhibit decreased IgG1, IgG2 (a and b) and IgG3 both pre- and post-immunization compared to wild-type chimeras
• fetal liver chimeras exhibit decreased IgG1, IgG2 (a and b) and IgG3 both pre- and post-immunization compared to wild-type chimeras
• fetal liver chimeras exhibit decreased IgG1, IgG2 (a and b) and IgG3 both pre- and post-immunization compared to wild-type chimeras
• in fetal liver chimeras following immunization

immune system
• following antigen stimulation in fetal liver chimeras, T cell proliferation is less than in similarly treated wild-type chimeras
• however, treatment with IL-2 results in normal proliferation rates
• in fetal liver chimeras, the percentage of B cell and CD11b+ cells in the lymph nodes and spleens is slightly lower than in wild-type chimeras
• in fetal liver chimeras, the number of T cells in the spleen is larger than in wild-type chimeras
• in fetal liver chimeras, the percentage of CD4+ and CD8+ cells in the lymph nodes and spleens is increased compared to in wild-type chimeras
• in fetal liver chimeras, the percentage of CD4+ and CD8+ cells in the lymph nodes and spleens is increased compared to in wild-type chimeras
• fetal liver chimeras exhibit decreased IgG1, IgG2 (a and b) and IgG3 both pre- and post-immunization compared to wild-type chimeras
• fetal liver chimeras exhibit decreased IgG1, IgG2 (a and b) and IgG3 both pre- and post-immunization compared to wild-type chimeras
• fetal liver chimeras exhibit decreased IgG1, IgG2 (a and b) and IgG3 both pre- and post-immunization compared to wild-type chimeras
• in fetal liver chimeras following immunization
• in T cells from fetal liver chimeras that were cultured with anti-CD3 and anti-CD28





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
09/17/2024
MGI 6.24
The Jackson Laboratory